Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DUOX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CIR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIM13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OPRM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC35F6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD163 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TSSK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADORA2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KRT24 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SMAD5-AS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
TYRO3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP11B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BNC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARID3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DKFZP586I1420 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TEX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PXDN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TTC28 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IRAK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C5AR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on